Your browser doesn't support javascript.
loading
Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma.
Lee, Victor H F; Kwong, Dora L W; Lam, Ka-On; Lai, Yu-Ching; Li, Yun; Tong, Chi-Chung; Ho, Patty P Y; Chan, Wing-Lok; Wong, Lai-San; Leung, Dennis K C; Chan, Sum-Yin; Chan, Fong-Ting; Leung, To-Wai; Lee, Anne W M.
Affiliation
  • Lee VHF; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.
Medicine (Baltimore) ; 96(15): e6518, 2017 Apr.
Article in En | MEDLINE | ID: mdl-28403082
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nasopharyngeal Neoplasms / Antineoplastic Agents, Alkylating / Cyclophosphamide / Neoplasm Recurrence, Local Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Medicine (Baltimore) Year: 2017 Document type: Article Affiliation country: Hong Kong Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nasopharyngeal Neoplasms / Antineoplastic Agents, Alkylating / Cyclophosphamide / Neoplasm Recurrence, Local Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Medicine (Baltimore) Year: 2017 Document type: Article Affiliation country: Hong Kong Country of publication: United States